Classes
- Internal Medicine - SE +1B00073 | First Faculty of Medicine
- Internal Medicine - Hematology +1B00307 | First Faculty of Medicine
- Review of Internal Diseases 1B00341 | First Faculty of Medicine
- Review of Internal Diseases 2B00355 | First Faculty of Medicine
- Ultrasonographic and Endoscopic TechnologyB00816 | First Faculty of Medicine
- Internal Medicine Practice before State Examination +1B01056 | First Faculty of Medicine
- Review of Internal Medicine - Rehabilitation 1B01536 | First Faculty of Medicine
- Diagnosis and therapy in haematology - ethical issuesB02094 | First Faculty of Medicine
- Laboratory Methods in Hematology - Diagnostic Tool and Translation´s Research +1B02551 | First Faculty of Medicine
- News in hematology and blood transfusionB02697 | First Faculty of Medicine
Publications
- Treatment of patients with relapsed/refractory Hodgkin lymphoma2011 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Treatment of patients with relapsed/refractory Hodgkin lymphoma2011 | First Faculty of Medicine
- CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group2011 | First Faculty of Medicine
- High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience2010 | First Faculty of Medicine, Third Faculty of Medicine
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.2010 | First Faculty of Medicine
- Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study.2010 | First Faculty of Medicine
- Rituximab based therapy followed by autologous stem cell transplantation leads to superior outcome and high rates of PCR negativity in patients with indolent B-cell lymphoproliferative disorders2009 | First Faculty of Medicine
- Implications of the European Organisation for Research And Treatment Of Cancer (EORTC) guidelines on the use of granulocyte colony-stimulating factor (G-CSF) for lymphoma care2009 | First Faculty of Medicine
- Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králov é
- Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...